Skip to main content
Download PDF

Clinical significance of dynamic variation of low cholesterol and its prognostic value in patients with pyogenic liver abscesses: a retrospective study

BMC Infectious Diseases volume 23, Article number: 70 (2023) Cite this article

Abstract

Background

Serum lipids variations are closely related to the sepsis progression; however, their value for patients with pyogenic liver abscesses (PLA) has rarely been studied. We investigated the serum lipid level variations in patients with PLA and its predictive value to the disease.

Methods

The study included 328 patients with PLA hospitalized in the First Affiliated Hospital of Nanjing Medical University from January 2017 to December 2021; 35 (10.67%) in the severe group (SG) and 293 (89.33%) in the non-severe group (nSG). Their clinical records were analyzed retrospectively, and dynamic curves were drawn to clarify the changes in different indicators during the course of the disease.

Results

High-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and lipoprotein(a) (Lp(a)) in the SG were significantly lower than those in nSG (P < 0.001). Total cholesterol (TC) at baseline (OR = 0.184, P < 0.001) was an independent risk factor for severe patients and had the highest predictive value, with an area under the curve of 0.859 and a cut-off value of 2.70 mmol/L (sensitivity = 94.3%, specificity = 63.5%). For patients who met the criteria for drainage surgery, TC, HDL-C and LDL-C levels continued to decrease with antibiotic therapy alone before drainage and began to increase after the surgery.

Conclusions

Low TC level on admission is an independent risk factor for the progression of severe illness in PLA patients, with the highest predictive value surpassing other routine clinical indices. Abscess drainage should be performed as soon as possible for patients whose TC continues to decline after medical treatment.

Peer Review reports

Background

The pyogenic liver abscess (PLA), a pyogenic infection, occurs owing to the liquefaction necrosis of liver parenchyma due to purulent bacterial invasion, including Escherichia coli, Klebsiella pneumoniae (K. pneumoniae), Pseudomonas aeruginosa, and Staphylococcus aureus. In general, it mainly occurs in middle-aged men with glucose intolerance or diabetes mellitus, possibly arising from the biliary tree; circulation (portal vein, hepatic artery); the adjacent focus of infection and penetrating trauma [1].

PLA gradually appeared in literature reports in the middle of the last century, and the mortality rate of PLA was as high as 50% owing to the limitation of medical treatment [2]. Currently, the development of imaging technology and antimicrobial and percutaneous drainage technologies have drastically improved the prognosis of patients with PLA [3]. However, adverse events may still occur owing to the lack of specific symptoms, being prone to sepsis or disseminated infection and the increase of multidrug-resistant K. pneumoniae infection, causing delayed diagnosis and treatment of PLA [4]. In recent reports, PLA has a mortality rate of 2–12% [5].

Serum lipids have been proven to be closely related to sepsis progression. Several studies have shown that patients with sepsis have decreased plasma total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), and subsequently, patients with low TC, HDL-C and LDL-C levels have higher death risk [6,7,8]. Additionally, patients with sepsis also have increased triglycerides (TG) and decreased lipoprotein(a) (Lp(a)) [9]. Previous studies have shown that patients with PLA generally present with leukocytosis, elevated alkaline phosphatase and abnormal liver function [10]; however, few studies have been conducted for assessing the condition and prognosis of PLA patients using lipid indices. Therefore, this study aimed to explore the variation of serum lipid levels in patients with PLA and its predictive value to the disease to provide a better reference for clinical diagnosis and treatment.

Methods

This retrospective study was performed following the Declaration of Helsinki Ethical Principles and was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (2020-SR-048). The requirement for informed consent was waived as existing residual medical records were used.

Study population

A total of 935 patients with PLA were admitted to the First Affiliated Hospital of Nanjing Medical University from January 2017 to December 2021. After screening by exclusion criteria, 328 cases were included.

The diagnostic criteria for PLA were as follows: (1) there were systemic symptoms such as fever and fatigue and/or local symptoms such as epigastric discomfort; (2) abdominal ultrasonography, computed tomography or magnetic resonance imaging findings suggesting liver abscess; (3) bacteriological culture results were positive and/or antimicrobial therapy was effective; and (4) percutaneous drainage or surgical treatment proved to be a bacterial suppurative infection. Patients who met criteria (3) or (4) based on criteria (1) and (2) were diagnosed as PLA.

Exclusion criteria were as follows: (1) PLA was not the leading cause of hospitalization; (2) the abscess was amoeba or tuberculous liver abscess; (3) patients with underlying hepatic disease, including viral hepatitis, autoimmune liver disease, fatty liver, cirrhosis, and liver cancer; (4) those with diseases known to cause dyslipidemia (besides diabetes), including hyperlipidemia, hypertension [11], chronic kidney disease [12], coronary heart disease, malignant tumor, hyperuricemia [13], and hyperthyroidism/hypothyroidism; (5) those taking medicines known to affect serum lipids, including lipid-regulating drugs, glucocorticoids, beta-blockers [14], and diuretics [15]; and (6) those who underwent surgery other than percutaneous drainage or laparoscopic abscess incision drainage during hospitalization.

Criteria for drainage were as follows: (1) Patient’s body temperature and symptoms did not return to normal or the condition deteriorated during antibiotic treatment; (2) re-examination of imaging suggested that the abscess had failed to shrink or continued to enlarge; and (3) the size and location of the abscess allowed puncture/incision drainage. Patients who met criteria (1) or (2) based on criteria (3) received drainage treatment in addition to antibiotic treatment.

Septic shock was diagnosed in septic patients with persisting hypotension requiring vasopressors to maintain MAP ≥ 65 mmHg and having a serum lactate level > 2 mmol/L despite adequate volume resuscitation [16]. The development of two or more concurrent organ dysfunctions was defined as multiple organ dysfunction syndromes (MODS).

Thirty-five of the 328 patients who developed septic shock or MODS (severe illness) were assigned to the severe group (SG), and the remaining 293 were assigned to the non-severe group (nSG). Eleven patients in the SG who died in a hospital or discontinued treatment owing to critical illness were classified as the death group. The remaining 317 patients who ameliorated after treatment were classified as the survival group. During the course of the disease, 59 and 269 patients who received antibiotic therapy alone without invasive remedies and received drainage treatment in addition to antibiotic treatment were classified as the medicine and drainage groups, respectively (Fig. 1).

Fig. 1
figure 1

Study flow chart

Full size image

The empirical treatment of PLA comprised carbapenem antibiotics like biapenem or meropenem in combination with metronidazole or ornidazole. Vancomycin or linezolid was added if necessary. Cefoperazone/sulbactam or moxifloxacin was used in patients with mild symptoms.

Bacterial identification

The isolated bacteria were identified using the VITEK 2 Compact (bioMérieux, France). Twenty clinical antibiotics commonly used were analyzed using the MIC method according to the guidelines of the Clinical and Laboratory Standards Institute. Quality control strains included Escherichia coli ATCC 25922 and Kleber pneumoniae ATCC 700603.

Data acquisition

The clinical data of patients with PLA were obtained from the medical record and laboratory report systems of our hospital. The baseline data were the results of the first venous sampling (mostly within 24 h after admission). Drainage group: Empiric antibiotic therapy was initiated for patients with PLA after admission; however, not all patients underwent abscess drainage immediately. Therefore, laboratory results were collected according to five periods for patients in the drainage group. When there were two or more laboratory results before drainage, the first result after admission was recorded as On admission, and the last result before drainage was recorded as Before drainage. However, when there was only one laboratory result before drainage if the time of blood sampling was more than 3 days before drainage (including the day of drainage treatment), it was recorded as On admission. If the time of blood sampling was ≤ 3 days before drainage, it was recorded as Before drainage. The duration from drainage to discharge was divided into three equal periods. The last result in each corresponding period was recorded as Drainage: earlyphase, Drainage: metaphase, and Before discharge. For patients in the medicine group, the first and second laboratory results after admission were collected and recorded as 1st sampling and 2nd sampling.

Statistical analysis

SPSS 26.0 software was used for statistical analysis. Continuous variables conforming to normal distribution were presented as mean ± standard deviation and compared using a t-test. Non-normal variables were presented as the median (interquartile range) and compared using the Mann–Whitney U test. Categorical data were presented as numbers (percentages) and were compared using Chi-square or Fisher exact test. The receiver operating characteristic (ROC) curve analysis was performed for serum lipid and other statistically significant indicators, and corresponding cut-off values were calculated. The independent predictors associated with the severity of PLA were identified using binary logistic regression. P < 0.05 was considered statistically significant.

Results

Characteristics of PLA patients

A total of 328 patients with PLA were enrolled in this study, including 222 males (67.68%) and 106 females (32.32%), with a median age of 56 (49–66) years. Among them, 153 cases (46.65%) had diabetes. More than 90% of the patients had been treated with antibiotics before hospitalization since the onset of the disease. Bacteriological culture (including blood culture or/and pus culture) was conducted in 272 patients (82.93%) during hospitalization. One hundred and ninety-five strains of bacteria were isolated from 190 patients with positive culture results, including 155 strains of K. pneumoniae (79.49%), 19 strains of Escherichia coli (9.74%), and 21 strains of other bacteria (10.77%) (Table 1) (see Additional file 1: Table S1).

Table 1 Characteristics of patients with pyogenic liver abscesses
Full size table

Comparison of baseline data

No significant differences in age, sex and body mass index (BMI) were observed between the SG and nSG (P > 0.05). The proportion of patients with diabetes and heat peak in the SG were higher than those in the nSG (P < 0.05). Differences in laboratory indicators between the two groups were ubiquitous. Compared to nSG, TC, HDL-C, LDL-C and Lp(a) in SG were significantly decreased (P < 0.001), while TG was significantly increased (P = 0.003). The discrepancies in other indicators such as liver function, blood routine and coagulation function were consistent with previous studies. No statistical difference was found in albumin and alkaline phosphatase (ALP) between the two groups (P > 0.05) (Table 2). TC, HDL-C, LDL-C and Lp (a) were also significantly lower in the death group than that in the survival group (P < 0.001) (see Additional file 1: Table S2).

Table 2 Comparison of baseline data between patients with PLA in the severe and non-severe groups
Full size table

ROC analysis of serum lipid and other indicators

ROC curve analysis was performed for serum lipids and other laboratory indices with statistical differences. TC and activated partial thromboplastin time (APTT) was demonstrated with the highest predictive value for severe patients, followed by LDL-C and HDL-C. The area under the curve (AUC) was 0.859, 0.859, 0.853 and 0.812, respectively. Using the cut-off value of 2.70 mmol/L, TC predicted severe illness with a sensitivity of 94.3% and specificity of 63.5%. TG has the lowest predictive value, with an AUC of 0.652. The AUC of other indicators mostly ranged from 0.7 to 0.8 (Fig. 2; see Additional file 1: Table S3). In addition to TG, serum lipid indices had higher predictive value for death patients. The AUC of TC reached 0.906. The sensitivity and specificity reached 81.8% and 87.4% respectively when the cut-off value was 1.98 (see Additional file 1: Table S4, Fig. S1).

Fig. 2
figure 2

ROC curves for the prediction of severe illness by laboratory indicators routinely measured in patients with PLA. TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; Lp(a): lipoprotein(a); TBIL: total bilirubin; DBIL: direct bilirubin; ALT: alanine transaminase; AST: aspartate transaminase; LDH: lactate dehydrogenase; WBC: white blood cell count; NE%: neutrophil percentage; HGB: hemoglobin; PLT: platelet; PT: prothrombin time; APTT: activated partial thromboplastin time; FIB: fibrinogen

Full size image

Logistic regression analysis of severe illness in PLA patients

TC with the highest AUC in serum lipid indices was selected for analysis. Other factors with P < 0.1 were screened using stepwise forward regression. Finally, TC, white blood cell count (WBC), platelet (PLT) and APTT were included in the regression analysis as independent variables. The results showed that independent risk factors for severe illness of patients with PLA were decreased TC (OR: 0.184, P < 0.001), PLT (OR: 0.991, P = 0.002), and increased WBC (OR: 1.119, P = 0.008), APTT (OR: 1.115, P = 0.010) (Table 3).

Table 3 Binary logistic regression analysis of factors for severe illness in patients with PLA
Full size table

Dynamic analysis of laboratory results in PLA patients

Drainage group (survival): the variation curves were drawn using the laboratory results of five periods before (On admission, Before drainage) and after (Drainage: earlyphase, Drainage: metaphase, Before discharge) drainage. During the period of antibacterial therapy alone before drainage, TC, HDL-C and LDL-C of patients with PLA reduced significantly, which began to rise gradually after drainage. TC before discharge was significantly higher than that on admission (P < 0.001), with a median increase of 0.6 mmol/L. Lp(A) had no significant change before drainage, but increased after it. No regularity was found in TG. After admission, alanine transaminase (ALT) and aspartate transaminase (AST) showed a decreasing trend. WBC and neutrophil percentage (NE%) were relatively stable before drainage; however, they decreased significantly after drainage (Fig. 3).

Fig. 3
figure 3

Variation curves of laboratory indices of patients with PLA in the drainage group (survival) during hospitalization. TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; Lp(a): lipoprotein(a); ALT: alanine transaminase; AST: aspartate transaminase; WBC: white blood cell count; NE%: neutrophil percentage. *Data in this period showed statistically significant difference compared with the previous period, P < 0.05; **P < 0.01; ***P < 0.001

Full size image

Medicine group: The first (1st sampling) and second (2nd sampling) laboratory results after admission were used for plotting variation curves. Different from the drainage group, patients in the medicine group showed an increase in TC, HDL-C, LDL-C and Lp(a), combined with a decrease in ALT, AST, WBC and NE%, which could be observed shortly after antibacterial treatment (Fig. 4).

Fig. 4
figure 4

Variation curves of laboratory indices of patients with PLA in the medicine group during hospitalization. TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; Lp(a): lipoprotein(a); ALT: alanine transaminase; AST: aspartate transaminase; WBC: white blood cell count; NE%: neutrophil percentage. *Data in this period showed statistically significant difference compared with the previous period, P < 0.05; **P < 0.01; ***P < 0.001

Full size image

Discussion

TC, HDL-C, LDL-C, TG and Lp(a) are the five serum lipid indices routinely detected in the biochemical examination of our hospital. Among them, TC, HDL-C and LDL-C (THL) show prosperous predictive value for the pathogenetic condition of patients with PLA. Results showed that THL decreased significantly in patients with severe illness. TC at baseline had the highest predictive value and was an independent risk factor for progression to severe illness.

HDL particles can bind and remove bacterial toxins, inhibit macrophage inflammatory responses, and prevent endothelial activation [17]. LDL particles have anti-inflammatory properties likewise [18]. As a result, THL decrease in patients with sepsis. As a center of lipid metabolism, THL decline has also been observed in patients with liver disease [19, 20]. Therefore, we believe that the co-existing pathophysiology of inflammatory consumption, liver injury and intake reduction in PLA play a synergistic role in the decline of THL, giving these indicators greater predictive value. As for other common abnormal laboratory indicators of patients with PLA, such as increased bilirubin, alkaline phosphatase and leukocytosis, all showed statistical differences in the baseline data analysis; however, with an inferior predictive value for TC and LDL-C.

As observed from the curve, the THL of patients in the drainage group decreased significantly when medication was administered before drainage. However, in the medicine group, THL recovery was observed after antibiotic treatment. Considering that reduced TC is an independent risk factor for patients with PLA to develop severe illness, THL can be used as references to judge the effectiveness of medical treatment and the necessity of abscess drainage. Abscess drainage should be performed as soon as possible if the patient’s THL continue to decline after empiric antimicrobial treatment, especially if TC drops below 2.70 mmol/L (sensitivity to predict severe illness was 94.3%). THL of patients displayed a rise after abscess drainage, and achieved the normal reference range before discharge, significantly higher than the level on admission, suggesting that THL can also be used as references for discharge. When TC level is more than 0.6 mmol/L higher than that on admission, the patient is considered to be recovering well and ready to be discharged.

The opposite variation trend of THL in the drainage and medicine groups after medicine therapy can widen the gaps of laboratory results between different patients to better identify the severity of patients. By contrast, ALT and AST in the drainage group showed an overall downward trend after admission. Most patients were treated with antibiotics before admission, and some with hepatoprotective drugs, which could explain the relatively low liver enzymes at admission. WBC and NE% were relatively stable before drainage; however, they were also susceptible to antimicrobial treatment, and the OR of WBC was close to 1. Therefore, their dynamic changes cannot be used as a strong reference for conditional judgment. We hypothesized that in patients requiring drainage therapy, sensitive antimicrobial therapy effectively inhibits abscess enlargement and further inflammatory damage to the surrounding liver tissue, which inhibits the increase of liver enzymes and WBC; however, it does not lead to rapid absorption and shrinkage of the abscess. The persistence of abscess leads to the intermittent entry of bacteria, toxins, and necrotic material into the bloodstream. Systemic inflammatory responses lead to continuous depletion of THL levels and consumption of the body; therefore, THL are of greater value in prognostic prediction.

TG and Lp(A) have little significance for patients with PLA. Although Lp(a) decreases in severe PLA patients and rises after drainage, it varies greatly among individuals. Results can fluctuate from tens to hundreds even in healthy individuals. Liver disease and reduced intake can lead to a decrease in TG, while various cytokines in sepsis can cause an increase in TG levels [21]. These two opposite effects achieved a relative balance in patients with PLA, resulting in irregular TG in data comparison and dynamic curve presentation.

This was a single-center retrospective study with some limitations. Most of the patients had received treatment before hospitalization, and the post-hospitalization examination results could not reflect the early onset of patients with PLA. Benefiting from the improvement of diagnosis and treatment, only a few patients with PLA developed into severe cases, and death was even rarer, which inevitably resulted in a large difference in sample sizes between groups.

Conclusion

Low TC levels on admission are an independent risk factor for the progression of severe illness in PLA patients, with the highest predictive value surpassing other routine clinical indices. Abscess drainage should be performed promptly for patients whose TC continues to decline after medical treatment.

Availability of data and materials

The data set generated and analyzed in the current study involved patient medical information. Public release of information was not approved by the ethics committee. Requests for further information should be directed to the corresponding author.

Abbreviations

PLA:

Pyogenic liver abscess

K. pneumoniae :

Klebsiella pneumoniae

TC:

Total cholesterol

HDL-C:

High-density lipoprotein cholesterol

LDL-C:

Low-density lipoprotein cholesterol

TG:

Triglyceride

Lp(a):

Lipoprotein(a)

MODS:

Multiple organ dysfunction syndrome

SG:

Severe group

nSG:

Non-severe group

ROC:

Receiver operating characteristic

BMI:

Body mass index

TBIL:

Total bilirubin

DBIL:

Direct bilirubin

ALT:

Alanine transaminase

AST:

Aspartate transaminase

ALP:

Alkaline phosphatase

LDH:

Lactate dehydrogenase

WBC:

White blood cell count

NE%:

Neutrophil percentage

HGB:

Hemoglobin

PLT:

Platelet

PT:

Prothrombin time

APTT:

Activated partial thromboplastin time

FIB:

Fibrinogen

AUC:

Areas under the curve

THL:

TC, HDL-C and LDL-C

References

  1. Khim G, Em S, Mo S, et al. Liver abscess: diagnostic and management issues found in the low resource setting. Br Med Bull. 2019;132(1):45.

    Article  CAS  Google Scholar 

  2. Lo JZ, Leow JJ, Ng PL, et al. Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. J Hepatobiliary Pancreat Sci. 2015;22(2):156–65.

    Article  Google Scholar 

  3. Haider SJ, Tarulli M, McNulty NJ, et al. Liver abscesses: factors that influence outcome of percutaneous drainage. AJR Am J Roentgenol. 2017;209(1):205–13.

    Article  Google Scholar 

  4. Liu J, Liu Y, Li C, et al. Clinical features and etiological analysis for 157 cases of pyogenic liver abscess. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021;46(7):711–8.

    Google Scholar 

  5. Lee CH, Jo HG, Cho EY, et al. Maximal diameter of liver abscess independently predicts prolonged hospitalization and poor prognosis in patients with pyogenic liver abscess. BMC Infect Dis. 2021;21(1):1–10.

    Article  CAS  Google Scholar 

  6. Hofmaenner DA, Kleyman A, Press A, et al. The many roles of cholesterol in sepsis: a review. Am J Respir Crit Care Med. 2022;205(4):388–96.

    Article  CAS  Google Scholar 

  7. Cirstea M, Walley KR, Russell JA, et al. Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis. J Crit Care. 2017;38:289–94.

    Article  CAS  Google Scholar 

  8. Lee JGH, Genga KR, Pisitsak C, et al. Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis. Crit Care. 2018;22(1):1–9.

    Article  Google Scholar 

  9. Mooser V, Berger MM, Tappy L, et al. Major reduction in plasma Lp (a) levels during sepsis and burns. Arterioscler Thromb Vasc Biol. 2000;20(4):1137–42.

    Article  CAS  Google Scholar 

  10. Davis J, McDonald M. Pyogenic liver abscess. UptoDate Sept, 2011.

  11. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol. 1990;15:S18-25.

    Article  CAS  Google Scholar 

  12. Bulbul MC, Dagel T, Afsar B, et al. Disorders of lipid metabolism in chronic kidney disease. Blood Purif. 2018;46(2):144–52.

    Article  CAS  Google Scholar 

  13. Peng TC, Wang CC, Kao TW, et al. Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int. 2015;2015:127596.

    Article  Google Scholar 

  14. Fonseca VA. Effects of beta-blockers on glucose and lipid metabolism. Curr Med Res Opin. 2010;26(3):615–29.

    Article  CAS  Google Scholar 

  15. Ames RP, Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension. Am J Med. 1976;61(5):748–57.

    Article  CAS  Google Scholar 

  16. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  Google Scholar 

  17. Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11):2071–7.

    Article  CAS  Google Scholar 

  18. Topchiy E, Cirstea M, Kong HJ, et al. Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor. PLoS ONE. 2016;11(5): e0155030.

    Article  Google Scholar 

  19. Cao WJ, Wang TT, Gao YF, et al. Serum lipid metabolic derangement is associated with disease progression during chronic HBV infection. Clin Lab. 2019. https://doi.org/10.7754/Clin.Lab.2019.190525.

    Article  Google Scholar 

  20. Janičko M, Veselíny E, Leško D, et al. Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients. Ann Hepatol. 2013;12(4):413–9.

    Article  Google Scholar 

  21. Feingold KR, Staprans I, Memon RA, et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992;33(12):1765–76.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the National Natural Science Foundation of China (No.81770591, No.81800778), Science and Technology Plan of Hainan Province (Clinical Research Center) (LCYX202103, LCYX202204), Hainan Province Science and Technology Special Fund (ZDYF2022SHFZ067), and Hainan Province Clinical Medical Center.

Author information

Authors and Affiliations

  1. Department of Infectious Disease, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd., Nanjing, 210029, China

    Tiantong Feng, Wen Zhang, Xiaoxue Hou, Hui Yuan, Jinyuan Cai, Zhengyi Jiang, Pingping Hu, Ming Yue & Chuanlong Zhu

  2. Department of Infectious and Tropical Diseases, The Second Affiliated Hospital of Hainan Medical University, 368 Yehai Ave., Haikou, 570311, China

    Wenting Li & Chuanlong Zhu

  3. Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Rd., Nanjing, 210029, China

    Yuwen Li

Authors
  1. Tiantong Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoxue Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hui Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jinyuan Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhengyi Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Pingping Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ming Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wenting Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chuanlong Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yuwen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TF, CZ and YL designed this study and wrote the manuscript text. YL and WZ conducted main statistical analysis. XH, HY and JC collected medical records. ZJ and PH screened the patients. MY, WL, CZ and YL critically revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Chuanlong Zhu or Yuwen Li.

Ethics declarations

Ethics approval and consent to participate

This retrospective study was performed following the Declaration of Helsinki Ethical Principles and was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (2020-SR-048). The requirement for informed consent was waived by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University because existing residual medical records were used in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

The composition of isolated bacteria. Table S2. Comparison of baseline data between patients with PLA in the death and survival groups. Table S3. Performance of different prognostic indicators on predicting severe illness of patients with PLA. Table S4. Performance of different prognostic indicators on predicting death of patients with PLA. Figure S1. Receiver operating characteristic (ROC) curves for the prediction of death by laboratory indicators routinely measured in patients with PLA.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, T., Zhang, W., Hou, X. et al. Clinical significance of dynamic variation of low cholesterol and its prognostic value in patients with pyogenic liver abscesses: a retrospective study. BMC Infect Dis 23, 70 (2023). https://doi.org/10.1186/s12879-023-08011-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-023-08011-7

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us